HIV Vaccine: Experiment to Re-engineer the Human Immune System

HIV Vaccine: Experiment to Re-engineer the Human Immune System


Since 1984, when Margaret Heckler,
US Health and Human Services Secretary, predicted that an AIDS vaccine
would be available in the US, pharmaceutical corporations like Merck
have tried to develop the elusive and highly profitable wonder
immunization.

For more than 3 decades, scientists have been working on an AIDS vaccine.

Trials conducted by Merck in 2007 actually
made those who took the vaccine more susceptible to the disease. Then
in 2009, human experiments in Thailand pointed drug corporations toward a
powerful vaccine that utilized immune system generated antibodies as
the answer to their dilemma.

New vaccines focus on tricking the human body to reject the HIV/AIDS
virus by manipulating the immune system. This mutation is suspected to
be able to assist the human body in identifying and neutralizing the
virus.

Scientific teams from various institutions like the Scripps Research Institute, the Rockefeller University, NIAID’s Vaccine Research Center and
Duke University are closely following how they can use the human body’s
immune system against the array of HIV strains that keep popping up.

US government intervention with the National Institutes of Health in
2005 identified the human immunodeficiency virus as the cause of AIDS.
Dr. Barton Haynes, of Duke University and director of the Center for HIV/AIDS Vaccine Immunology (CHAVI) asserted that: “We know the face of the enemy.”


Colonel Nelson Michael, director of the US Military HIV Research Program at the Walter Reed Army Institute of Research,
who led the government experimentation of the RV144 trial, commented
that since Merck’s vaccine trials “had a chilling effect” that
uncircumcised males have an increased risk for infection prior to
exposure to the vaccine. The WRAIR went into Uganda, Kenya and Tanzania
to conduct human experimentation of compromising the human immune system
under the cover of HIV/AIDS research for vaccination purposes.

Hayes’ research showed that vaccinated men and women developed
antibodies in the region of the virus’s outer coat, which suggests that
this element should be further studied.

New experimental trials will take place in Thailand, using a Sanofi vaccine that has an additive from Norvartis.

Michael
urges financing for the relationship between Sanofi and Norvartis where
vaccines will be deployed in South Africa where a suspect and different
strain of HIV has been identified. Michael’s team is also working with
Harvard University’s Johnson & Johnson Crucell unit (JJCU) which has varied versions of the common cold virus and the smallpox virus on hand for “research purposes”.

The JJCU is a collaborative effort of Merck, the National Institutes of
Medicine and other biotech corporations that specialize in researching
the viral effects of genetically engineered viruses on the human and
animal immune system.

After the human experiments are finished, pharmaceutical corporations
hope to have a licensed HIV vaccine available to the public by 2019.

Progress on the AIDS vaccine will be released at the International AIDS Society 2012 conference (IAS) in Washington, DC later this month; of which Hayes will be a guest speaker.

The IAS conference endeavors to certain international goals and objectives:

• Align the scientific community to combine research and development.
  
• Control promotion of AIDS information and influence policymakers.
  
• Target specific age groups for promotion of HIV vaccine necessity.
  
• Study the impact of HIV on densely populated nations.
  
• Mandate international support for HIV immunizations.
  
• Use government and private-sector laboratory research funded by the international community, governments and donations.
  
• Provide propaganda concerning the emergence of an HIV epidemic, and
  integrate healthcare systems to respond as outlined by international
  mandate.
  

Gottfried Himschall, HIV/AIDS chief at the World Health Organization (WHO) announced that
pharmacological research will create an “arsenal of drugs” that could
“help end new infections.” Although Himschall admits that drug
corporations' answer for HIV vaccines “are still not perfect”, he is
convinced that research into preventing HIV in healthy people is the way
to go.

Current experiments into the nature of HIV/AIDS, and the human immune system’s response to the virus, extend back to the 1980s. Wangari Maathai,
a Kenyan ecologist and Nobel Peace Prize winner, vehemently asserted
that HIV was created in a laboratory deliberately as a bio-weapon for
population control. Maathai said:

Some say that AIDS came from the monkeys,
and I doubt that because we have been living with monkeys (since) time
immemorial, others say it was a curse from God, but I say it cannot be
that. And that HIV was created with the intention as an
“agent to wipe out other people . . . In fact [the HIV virus] was
created by a scientist for biological warfare. Why has there been so
much secrecy about AIDS? When you ask where did the virus come from, it
raises a lot of flags. That makes me suspicious.”

Under cover of a smallpox vaccine initiative,
WHO went into Africa where an estimated 100 million Africans were
inoculated. The immunization was actually a cancer-causing
immunosuppressive virus that was developed by the National Cancer
Institute (NCI).

Dr. Robert Strecker has explained in his books that Africans were
infected with HIV during the smallpox vaccine distribution; as laid out
by WHO in a memorandum from 1972. Prior to 1979, there were no reported
cases of HIV/AIDS in Africa, according to Luc Montagnier, a French
Pasteur scientist.

US government-sponsored experiments in 1978 – 1981 with homosexual males produced an official AIDS epidemic that originated in New York City.

According to an annual volume of the Special Cancer Virus Program,
human experimentation with cancer-causing and immunosuppressive viruses
was essential. With the “gay plague” and "gay cancer", such experiments
were no longer necessary. The deaths of thousands of gay men proved
that these viruses caused cancer, immunosuppression, and were sexually
transmissible between people.

HIV/AIDS has been developed as a bio-weapon of mass depopulation
capabilities, but now the global Elite are stepping up their intention
with research into the abilities of the human immune system, which could
result in a “vaccine” that would cause the human immune system to
become ineffective.

By claiming there is a pandemic, the global Elite could
justify the need for mass immunizations. This would leave every person
inoculated under threat of becoming deathly ill from even simple
exposure to the common cold.


Source:-
http://www.activistpost.com/2012/07/hiv-vaccine-experiment-to-re-engineer.html